| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |